Condition: Femoral Fractures · Hip Arthropathy · Sponsor: Limacorporate S.p.a
Study design: monocentric, retrospective, observational and post-market clinical study. Purpose: To demonstrate the safety and performance of CoCrMo LOCK bipolar femoral heads. The eligible study population is represented by the entire population that underwent a hip replacement with CoCrMo LOCK bipolar femoral heads from 1st January 2023 onwards at the site in accordance with the indication for use of the product.
This description comes directly from the study's public registry record.
Monica Novello · 3358162087 · monica.novello@enovis.com
Francesca Citossi · +39 0432 945511 · clinicalresearch@enovis.com
Always discuss trial participation with your own doctor first.
| Splošna bolnišnica Celje | Celje, Slovenia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06885359